Advertisement

Sepsis and Acute Lung Injury

  • G. R. Bernard
  • E. Holden
  • J. W. Christman
Chapter
  • 49 Downloads
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 19)

Abstract

Sepsis syndrome is associated with diffuse microvascular injury (predominantly lung injury) which appears to be related to a wide variety of physiologically active and tissue destructive mediators. The exact cause and effect relationship between mediators and pathophysiology is becoming increasingly better understood but much remains to be elucidated. Even in those situations where biochemical mechanisms have been well worked out in animal models, it remains to be seen whether or not the findings can be transferred to humans with sepsis. The tremendous homogeneity of the sepsis syndrome population make clinical studies of this group difficult and meaning of clinical findings subject to interpretation. Increasingly, however, the availability of high quality assays and pharmacologic interventions has placed this type of research on more firm footing. In this chapter, the clinical implications of the release of bioactive lipids and free radicals of oxygen will be explored in the light of the available clinical data just now becoming available.

Keywords

Acute Lung Injury Idiopathic Pulmonary Fibrosis Adult Respiratory Distress Syndrome Bioactive Lipid Sepsis Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365–376PubMedCrossRefGoogle Scholar
  2. 2.
    Bone RC, Balk RA, Cerra FB, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644–1655PubMedCrossRefGoogle Scholar
  3. 3.
    Grisham MB, McCord J (1986) Chemistry and cytotoxicity of reactive oxygen metabolites. In: Taylor AE, Matalón S, Ward PA (eds) Physiology of oxygen radicals. American Physiologic Society, Bethesda, MD, pp 1–18Google Scholar
  4. 4.
    Parks D, Granger DN (1986) Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand 548: 87–99Google Scholar
  5. 5.
    Bernard GR, Korley V, Chee P, et al (1991) Persistent generation of peptido leuko- triene in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 144: 262–267Google Scholar
  6. 6.
    Brigham KL, Meyrick B, Bernard GR (1986) Free radicals and arachidonic acid metabolites in endotoxin-induced pulmonary endothelial injury. In: Taylor AE, Matalón S, Ward PA (eds) Physiology of oxygen radicals. American Physiologic Society, Bethesda, MD, pp 1–18Google Scholar
  7. 7.
    Christman BW, Lefferts PL, King GA, Snapper JR (1988) Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction in awake sheep. J Appl Physiol 64: 2033–2041PubMedGoogle Scholar
  8. 8.
    Coggeshall JW, Christman BW, Lefferts PL, et al (1988) Effect of inhibition of 5-lip- oxygenase metabolism of arachidonic acid on response to endotoxemia in sheep. J Appl Physiol 65: 1351–1359PubMedGoogle Scholar
  9. 9.
    Brigham KL, Zadoff A, Serafín WE, Oates JA (1985) Prostaglandin E2 (PGE2) attenuates the pulmonary vascular response to endotoxemia in unanesthetized sheep. Clin Res 33: 579 (Abst)Google Scholar
  10. 10.
    Holcroft JW, Vassar MJ, Weber CJ (1986) Prostaglandin Ei and survival in patients with the adult respiratory distress syndrome: A prospective trial. Ann Surg 203: 371–378PubMedCrossRefGoogle Scholar
  11. 11.
    Bone RC, Slotman G, Maunder R, et al (1989) Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Chest 96: 114–119PubMedCrossRefGoogle Scholar
  12. 12.
    Brigham KL (1985) Metabolites of arachidonic acid in experimental vascular lung injury. Federation Proc 44: 43–45Google Scholar
  13. 13.
    Oppenheim JJ, Zachariae COC, Mukaida N, et al (1991) Properties of the novel proin-flammatory supergene “intercrine” cytokine family. Annu Rev Immunol 9: 617–648PubMedCrossRefGoogle Scholar
  14. 14.
    Donnelly SC, Strieter RM, Kunkel SL, et al (1993) Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341: 643–647PubMedCrossRefGoogle Scholar
  15. 15.
    Richman-Eisenstat JB, Jorens PG, Hebert CA, et al (1993) Interleukin-8: An important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 264: L413–418PubMedGoogle Scholar
  16. 16.
    Dean TP, Dai Y, Shute JK, et al (1993) Interleukin 8 concentration are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatric Res 34: 162–166Google Scholar
  17. 17.
    Hack CE, Hart M, van Schijndel RJ, et al (1992) Interleukin-8 in sepsis: Relation to shock and inflammatory mediators. Infec Immun 60: 2835–2842Google Scholar
  18. 18.
    Haistensen A, Ceska M, Brandtzaeg P, et al (1993) Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis 167: 471–475CrossRefGoogle Scholar
  19. 19.
    Carre PC, Mortenson RL, King TE, et al (1991) Increased expression of the interleukin 8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 88: 1802–1810PubMedCrossRefGoogle Scholar
  20. 20.
    Broaddus VC, Hebert CA, Vitangcol RV, et al (1992) Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis 146: 825–830PubMedGoogle Scholar
  21. 21.
    Metinko AP, Kunkel SL, Standiford TJ, Strieter RM (1992) Anoxia-hyperoxia induced monocyte-derived interleukin-8. J Clin Invest 90: 791–798PubMedCrossRefGoogle Scholar
  22. 22.
    DeForge LE, Fantone JC, Kenney JS, Remick DG (1992) Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J Clin Invest 90: 2123–2129PubMedCrossRefGoogle Scholar
  23. 23.
    Mukaida N, Mahe Y, Matsushima K (1990) Cooperative interaction of nuclear factor- kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biolog Chem 265: 21128–21133Google Scholar
  24. 24.
    Mukaida N, Shiroo M, Matsushima K (1989) Genomic structure of the human mono- cyte-derived neutrophil chemotactic factor IL-8. J Immunol 143: 1366–1371PubMedGoogle Scholar
  25. 25.
    Schreck R, Albermann K, Baeuerle PA (1992) Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Rad Res Comm 17: 221–237CrossRefGoogle Scholar
  26. 26.
    Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-KB transcription factor and HIV-1. EMBO J 10: 2247–2258PubMedGoogle Scholar
  27. 27.
    Toledano MB, Leonard WJ (1991) Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sei USA 88: 4328–4332CrossRefGoogle Scholar
  28. 28.
    Hayashi T, Ueno Y, Okamoto T (1993) Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J Biolog Chem 268: 11380–11388Google Scholar
  29. 29.
    Schreck R, Grassmann R, Fleckenstein B, Baeuerle PA (1992) Antioxidants selectively suppress activation of NF-KB by human T-cell leukemia virus type I Tax protein. J Virol 66: 6288–6293PubMedGoogle Scholar
  30. 30.
    Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA (1992) Dithiocarbamates as potent inhibitors of nuclear factor KB activation in intact cells. J Exper Med 175: 1181–1194CrossRefGoogle Scholar
  31. 31.
    Martensson J, Jain A, Frayer W, Meister A (1989) Glutathione metabolism in the lung: Inhibition of its synthesis leads to lamellar body and mitochondrial defects. Proc Natl Acad Sci USA 86: 5296–5300PubMedCrossRefGoogle Scholar
  32. 32.
    Pacht ER, Timerman AP, Lykens MG, Merola AJ (1991) Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100: 1397–1403PubMedCrossRefGoogle Scholar
  33. 33.
    Bernard GR (1991) N-acetylcysteine in experimental and clinical acute lung injury. Am J Med 91 (Suppl 3c): 54–59CrossRefGoogle Scholar
  34. 34.
    Bernard GR, Lucht WD, Niedermeyer ME, et al (1984) Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 73: 1772–1784PubMedCrossRefGoogle Scholar
  35. 35.
    Forman MB, Puett DW, Cates CU, et al (1990) Glutathione redox pathway and reper- fusion injury. Effect of N-acetylcysteine on infarct size. Circulation 78: 202–213CrossRefGoogle Scholar
  36. 36.
    Suter PM, Domenighetti G, Schaller MD, Laverriere MC, Ritz R, Perret C (1994) N-acetylcysteine enhances recovery from acute lung injury in man: A randomized, double-blind, placebo-controlled clinical study. Chest 105: 190–194PubMedCrossRefGoogle Scholar
  37. 37.
    Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen MO (1992) Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study. Crit Care Med 20: 918–923PubMedCrossRefGoogle Scholar
  38. 38.
    Bernard GR, Reines HD, Halushka PV, et al (1991) Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome: Effects of cyclooxygenase inhibition. Am Rev Respir Dis 144: 1095–1101PubMedCrossRefGoogle Scholar
  39. 39.
    Snapper JR, Hutchison AA, Ogletree ML, Brigham KL (1983) Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the un- anesthetized sheep. J Clin Invest 72: 63–76PubMedCrossRefGoogle Scholar
  40. 40.
    Wright PW, Bernard GR (1989) Mechanisms of the late hemodynamic and airway me-chanics response to endotoxin in the awake sheep. Am Rev Respir Dis 140: 672–678PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • G. R. Bernard
  • E. Holden
  • J. W. Christman

There are no affiliations available

Personalised recommendations